felodipine has been researched along with Alloxan Diabetes in 6 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study we evaluated the effect of global brain ischemia on brain metabolic parameters in normal and diabetic rats treated with a dihydropyridine calcium antagonist, felodipine." | 3.72 | The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers. ( Dunbar, JC; Levy, J; Zhu, Z, 2004) |
| " Therefore, the present study using thermal pain threshold was taken up to find out, whether felodipine, altered morphine analgesia in experimental diabetes." | 3.69 | Felodipine potentiates morphine analgesia in control and streptozotocin diabetic female rats. ( Andrade, C; Chandran, U; Rani, MA; Venkataraman, BV, 1996) |
| "Felodipine was administered (po) for 4 week to rats with streptozotocin-diabetes of 4 week duration." | 1.29 | Effect of felodipine on myocardial function and cholinergic responses in short term streptozotocin diabetes in rats. ( Andrade, C; Jaiprakash, R; Rani, MA; Venkataraman, BV, 1994) |
| "Enalapril treatment (5 mg/kg/day, n = 11) or felodipine (30 mg/kg/day, n = 11) reduced systolic blood pressure to a comparable degree." | 1.27 | Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. ( Cubela, R; Debrevi, L; Jackson, B; Johnston, CI; Whitty, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levy, J | 1 |
| Zhu, Z | 1 |
| Dunbar, JC | 1 |
| Jaiprakash, R | 3 |
| Rani, MA | 4 |
| Venkataraman, BV | 4 |
| Andrade, C | 4 |
| Chandran, U | 1 |
| Jackson, B | 1 |
| Cubela, R | 1 |
| Debrevi, L | 1 |
| Whitty, M | 1 |
| Johnston, CI | 1 |
6 other studies available for felodipine and Alloxan Diabetes
| Article | Year |
|---|---|
The effect of global brain ischemia in normal and diabetic animals: the influence of calcium channel blockers.
Topics: Adenosine Triphosphate; Animals; Brain Chemistry; Brain Ischemia; Calcium; Calcium Channel Blockers; | 2004 |
Effect of felodipine on cholinergic responses of the colonic smooth muscle of streptozotocin induced diabetic rats.
Topics: Acetylcholine; Animals; Colon; Diabetes Mellitus, Experimental; Felodipine; Female; Male; Muscle, Sm | 1995 |
Effect of felodipine on myocardial function and cholinergic responses in short term streptozotocin diabetes in rats.
Topics: Acetylcholine; Animals; Diabetes Mellitus, Experimental; Felodipine; Female; Male; Myocardial Contra | 1994 |
Effect of felodipine on serum lipid profile in short term streptozotocin-diabetes in rats.
Topics: Animals; Cholesterol; Diabetes Mellitus, Experimental; Felodipine; Female; Lipids; Male; Rats; Rats, | 1993 |
Felodipine potentiates morphine analgesia in control and streptozotocin diabetic female rats.
Topics: Analgesics, Opioid; Animals; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Drug Synergi | 1996 |
Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Diabetes Mellitus, Expe | 1987 |